Notice ID: ed3f19f5dfc840ca801651deebc90227Solicitation
RFP - Intranasal Nalmefene Drug-Device Combination
Archived on September 30, 2023. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 2:00 PM UTC−04:00
- Posted
- August 19, 2023
- Notice type
- Solicitation
- Agency
- Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Notice details
- Office
- ASPR BARDA DIV CONTRACTS MGMT & ACQ
- Place of performance
- Washington, DC, 20024
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75A50123R00003
- Notice ID
- ed3f19f5dfc840ca801651deebc90227
Description
The Office of the Biomedical Advanced Research and Development Authority within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) intends to use Project BioShield (PBS) to support to the procurement of an intranasal nalmefene drug-device combination product for use by adult and pediatric populations for the treatment of opioid, including fentanyl overdose. Please see attached solicitation. Amendment 1 provides responses to vendor questions.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75A50123R00003- Solicitation
Award typically follows within 30–90 days after the response deadline. (estimate)
- 2×SolicitationCurrentAug 1, 2023
RFP - Intranasal Nalmefene Drug-Device Combination
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75A50123R00003
Archive Date
Sep 30, 2023
Office Address
Washington, DC, 20515